A detailed history of Quantbot Technologies LP transactions in Schrodinger, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 13,601 shares of SDGR stock, worth $306,974. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,601
Previous 28,540 52.34%
Holding current value
$306,974
Previous $551,000 54.26%
% of portfolio
0.01%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.05 - $24.02 $269,648 - $358,834
-14,939 Reduced 52.34%
13,601 $252,000
Q2 2024

Aug 09, 2024

BUY
$18.65 - $28.5 $532,271 - $813,390
28,540 New
28,540 $551,000
Q4 2023

Feb 14, 2024

BUY
$21.62 - $37.21 $103,819 - $178,682
4,802 Added 36.1%
18,103 $648,000
Q3 2023

Nov 07, 2023

BUY
$27.34 - $55.37 $363,649 - $736,476
13,301 New
13,301 $376,000
Q4 2022

Feb 13, 2023

BUY
$16.24 - $26.38 $20,153 - $32,737
1,241 Added 6.97%
19,040 $355,000
Q3 2022

Nov 07, 2022

SELL
$23.95 - $34.71 $334,581 - $484,898
-13,970 Reduced 43.97%
17,799 $444,000
Q2 2022

Aug 09, 2022

BUY
$21.39 - $35.9 $547,883 - $919,542
25,614 Added 416.15%
31,769 $839,000
Q1 2022

May 16, 2022

SELL
$24.84 - $36.12 $46,972 - $68,302
-1,891 Reduced 23.5%
6,155 $210,000
Q4 2021

Feb 11, 2022

SELL
$33.38 - $59.25 $259,963 - $461,439
-7,788 Reduced 49.19%
8,046 $280,000
Q3 2021

Nov 09, 2021

BUY
$53.75 - $76.55 $795,983 - $1.13 Million
14,809 Added 1444.78%
15,834 $865,000
Q2 2021

Aug 12, 2021

BUY
$59.02 - $78.8 $60,495 - $80,770
1,025 New
1,025 $77,000
Q1 2021

May 14, 2021

SELL
$64.61 - $113.09 $494,654 - $865,817
-7,656 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$48.06 - $84.4 $318,301 - $558,981
-6,623 Reduced 46.38%
7,656 $606,000
Q3 2020

Nov 16, 2020

BUY
$46.87 - $93.33 $669,256 - $1.33 Million
14,279 New
14,279 $678,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.4B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.